Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew R. Allen currently holds 660,000 shares of Epizyme, Inc. (EPZM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew R. Allen has been a net seller of EPZM stock. They have purchased $158.2K and sold $12.1M worth of shares.
Andrew R. Allen's most recent insider trade was on Jul 1, 2024, when they sold 660,000 shares at $0.00 per share.
Andrew R. Allen serves as Executive at Epizyme, Inc. (EPZM). They have executed 52 insider transactions totaling $12.2M over their tenure at the company.
Andrew R. Allen holds the position of Executive at Epizyme, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Andrew R. Allen has shown a selling trading pattern, with $158.2K in total purchases and $12.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew R. Allen was on Jan 16, 2015, when they sold $3.3M worth of CLVS shares. This transaction involved 49,176 shares at $66.26 per share.
Andrew R. Allen currently owns 660,000 shares of Epizyme, Inc. (EPZM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew R. Allen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew R. Allen has 52 Form 4 filings on record as an insider at Epizyme, Inc..
Set alerts for Andrew R. Allen and 40,000+ other insiders.